Related Experiment Video

Updated: Jun 10, 2026

A Chronic Cardiac Ischemia Model in Swine Using an Ameroid Constrictor
08:22

A Chronic Cardiac Ischemia Model in Swine Using an Ameroid Constrictor

Published on: October 9, 2017

The cardiologist--a chained Prometheus

Robespierre Queiroz da Costa Ribeiro1

  • 1Secretaria de Estado de Saúde de Minas Gerais, Belo Horizonte, MG, Brasil. rqueiroz@cardiol.br

Arquivos Brasileiros De Cardiologia
|August 10, 2010
PubMed

Insights

Healthcare resources are misallocated, prioritizing costly treatments for diseases like cardiovascular disease and type 2 diabetes over cost-effective health promotion. This approach neglects preventative strategies, leading to healthcare inequities.

Area of Science:

  • Paleomedicine
  • Public Health
  • Health Economics

Background:

  • The Flexnerian model of medical education and practice remains dominant.
  • Knowledge of disease burden and determinants is extensive.
  • Current healthcare systems face challenges in effectively addressing major diseases.

Purpose of the Study:

  • To critically review deviations from the Flexnerian model.
  • To analyze resource allocation in healthcare.
  • To evaluate the effectiveness of health promotion versus treatment.

Main Methods:

  • Critical review of existing literature.
  • Analysis of paleomedicine perspectives.
  • Examination of healthcare resource allocation patterns.

Main Results:

  • Significant resources are allocated to treating ischemic cardiovascular diseases and type 2 diabetes mellitus.
  • Risk factors for these diseases are well-understood and modifiable through health promotion.
  • Health promotion is a more cost-effective strategy than biotechnology.

Conclusions:

  • Current healthcare practices deviate from optimal resource allocation.
  • There is an overemphasis on individual treatment over population-level health promotion.
  • This imbalance represents a significant healthcare injustice.

More Related Videos

Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...